Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol on Live Birth Rate for Freeze-all Cycles: Recruitment is Slow Due to COVID19

NCT04052607 is registered in ClinicalTrials.gov with Ibn Sina Hospital as lead sponsor.

NCT NCT04052607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04052607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol on Live Birth Rate for Freeze-all Cycles: Recruitment is Slow Due to COVID19
Lead sponsor
Ibn Sina Hospital
Phase
Not applicable
Overall status
Terminated
Start date
September 10, 2019
Completion date
April 30, 2020
Enrollment
56 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infertility